Dyslipidemia
Conditions
Interventions
In addition to the usual care, the pharmacist evaluates lifestyle-related habits and provides medication information.
Usual care
Sponsors
Showa University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Taking statins 2)Ingredients and daily dose of dyslipidemia drug have not changed for 6 months or more 3)Have at least one of LDL-C 140 mg / dL or more, HDL-C less than 40 mg / dL, systolic blood pressure 140 mmHg or more, and diastolic blood pressure 90 mmHg or more. 4)Written consent can be obtained from the individual regarding participation in this study.
Exclusion criteria
Exclusion criteria: 1) Familial Hypercholesterolemia 2)History of coronary artery disease 3)Diabetes,chronic kidney disease (CKD),noncardiogenic cerebral infarction,peripheral arterial disease (PAD) 4) Taking medicine for dementia / mental illness 5) Have serious illness including dialysis 6) Intervention less than 3 times in 8 months 7) Blood biochemical test values (LDL-C, HDL-C, TG) cannot be confirmed 8) Those who are judged to be unsuitable for research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Suita score for patients with dyslipidemia | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in LDL-C, HDL-C, TG, non-HDL-C,blood pressure and body weight Rubric score (intervention group) Questionnaire Proportion of days covered(PDC) | — |
Countries
Japan
Contacts
Public ContactMasayuki Ohbayashi
Showa University Department of Pharmacotherapy, Department of Clinical Pharmacy,School of Pharmacy
Outcome results
None listed